Malignant solid neoplasm Trials in Rochester, United States
Conditions / Malignant solid neoplasm / Rochester, United States
Malignant solid neoplasm is a medical condition with active clinical research programs worldwide.
49 total trials for this combination
Showing top 10 of 49 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT06513962 | Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer | RECRUITING | PHASE3 |
| NCT06126276 | Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial) | RECRUITING | — |
| NCT03223753 | Web-Based Physical Activity Intervention in Improving Long Term Health in Children and Adolescents With Cancer | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT04387656 | NCI COVID-19 in Cancer Patients, NCCAPS Study | ACTIVE_NOT_RECRUITING | — |
| NCT04284774 | Tipifarnib for the Treatment of Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With HRAS Gene Alterations, a Pediatric MATCH Treatment Trial | ACTIVE_NOT_RECRUITING | PHASE2 |
| NCT02834013 | Nivolumab and Ipilimumab in Treating Patients With Rare Tumors | ACTIVE_NOT_RECRUITING | — |
| NCT04387656 | NCI COVID-19 in Cancer Patients, NCCAPS Study | ACTIVE_NOT_RECRUITING | — |
| NCT02402244 | Project: Every Child for Younger Patients With Cancer | RECRUITING | — |
| NCT03213652 | Ensartinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With ALK or ROS1 Genomic Alterations (A Pediatric MATCH Treatment Trial) | ACTIVE_NOT_RECRUITING | PHASE2 |
| NCT02717507 | Carvedilol in Preventing Heart Failure in Childhood Cancer Survivors | COMPLETED | PHASE2 |